J B Chemicals and Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
JBCHEPHARM
Pharmaceuticals
Share Price NSE
₹2000.30
▲
7.90 (0.40%)
Share Price BSE
₹2001.25
▲
11.90 (0.60%)
Track J B Chemicals and Pharmaceuticals share price live with TickJournal's free stock screener.
Analyze J B Chemicals and Pharmaceuticals share price history trends and compare 52-week high low
levels.
Calculate JBCHEPHARM stock fair value using fundamental analysis and view live share price charts.
Determine J B Chemicals and Pharmaceuticals share intrinsic value and compare it with current JBCHEPHARM share price.
Record your J B Chemicals and Pharmaceuticals trades in TickJournal's free trading journal and track your portfolio performance.
J B Chemicals and Pharmaceuticals Market Cap
₹29,635.23 Cr.
EPS (TTM)
₹42.45
Dividend Yield
0.79%
Debt to Equity
0.06
JBCHEPHARM 52 Week High
₹2000.30
J B Chemicals and Pharmaceuticals 52 Week Low
₹1504.40
Operating Margin
24.00%
Profit Margin
15.15%
JBCHEPHARM Revenue (TTM)
₹964.00
EBITDA
₹241.00
Net Income
₹146.00
Total Assets
₹4,274.00
Total Equity
₹3,433.00
J B Chemicals and Pharmaceuticals Share Price History - Stock Screener Chart
Screen JBCHEPHARM historical share price movements with interactive charts. Analyze price trends and patterns.
J B Chemicals and Pharmaceuticals Company Profile - Fundamental Screener
Screen J B Chemicals and Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JBCHEPHARM shares.
J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Arun Duggal
ISIN
INE572A01036
Website
https://www.jbpharma.com
J B Chemicals and Pharmaceuticals Balance Sheet Screener
Screen JBCHEPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 4,274 | 3,994 | 3,554 | 2,607 | 2,238 | 1,821 | 1,792 | 1,765 | 1,674 | 1,648 |
| Current Assets | 1,923 | 1,853 | 1,528 | 1,253 | 1,553 | 1,073 | 1,051 | 1,047 | 795 | 816 |
| Fixed Assets | 1,968 | 2,004 | 1,901 | 1,277 | 634 | 651 | 621 | 640 | 679 | 440 |
| Liabilities | ||||||||||
| Total Liabilities | 4,274 | 3,994 | 3,554 | 2,607 | 2,238 | 1,821 | 1,792 | 1,765 | 1,674 | 1,648 |
| Current Liabilities | 208 | 203 | 519 | 85 | 79 | 69 | 65 | 46 | 27 | 31 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 3,433 | 2,923 | 2,480 | 2,139 | 1,813 | 1,438 | 1,483 | 1,444 | 1,366 | 1,186 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 | 17 |
| Reserves & Surplus | 3,418 | 2,908 | 2,465 | 2,119 | 1,794 | 1,420 | 1,464 | 1,425 | 1,347 | 1,167 |
J B Chemicals and Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen J B Chemicals and Pharmaceuticals income statement and profit fundamentals.
Analyze JBCHEPHARM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for J B Chemicals and Pharmaceuticals share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 964 | 1,109 | 1,100 | 1,083 | 878 | 1,010 | 1,011 | 972 | 767 | 902 | 889 | 852 | 627 | 786 | 811 |
| Expenses | 723 | 793 | 775 | 769 | 664 | 724 | 730 | 709 | 599 | 664 | 638 | 621 | 500 | 612 | 625 |
| EBITDA | 241 | 315 | 325 | 314 | 215 | 286 | 281 | 263 | 168 | 238 | 251 | 231 | 127 | 174 | 186 |
| Operating Profit % | 24.00% | 28.00% | 29.00% | 28.00% | 23.00% | 28.00% | 27.00% | 26.00% | 21.00% | 26.00% | 28.00% | 26.00% | 20.00% | 22.00% | 23.00% |
| Depreciation | 46 | 43 | 44 | 45 | 41 | 41 | 42 | 42 | 32 | 31 | 32 | 34 | 22 | 26 | 28 |
| Interest | 2 | 1 | 1 | 2 | 9 | 6 | 2 | 3 | 14 | 12 | 10 | 13 | 2 | 6 | 8 |
| Profit Before Tax | 193 | 272 | 279 | 267 | 165 | 240 | 237 | 218 | 123 | 194 | 209 | 184 | 103 | 142 | 150 |
| Tax | 47 | 69 | 71 | 69 | 38 | 63 | 62 | 56 | 35 | 52 | 58 | 50 | 18 | 37 | 39 |
| Net Profit | 146 | 202 | 208 | 198 | 126 | 177 | 175 | 163 | 88 | 142 | 151 | 134 | 85 | 105 | 111 |
| EPS | 9.36 | 12.99 | 13.29 | 12.63 | 8.22 | 11.39 | 11.24 | 10.46 | 11.33 | 9.20 | 9.72 | 8.62 | 10.98 | 13.59 | 14.37 |
J B Chemicals and Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen JBCHEPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 903 | 801 | 626 | 170 | 315 | 276 | 194 | 123 | 201 | 140 |
| Investing Activities | -296 | -404 | -962 | 2 | -231 | 24 | -28 | -21 | -45 | -26 |
| Financing Activities | -580 | -386 | 357 | -138 | -87 | -306 | -156 | -60 | -184 | -100 |
| Net Cash Flow | 27 | 11 | 20 | 34 | -3 | -6 | 11 | 43 | -28 | 15 |
J B Chemicals and Pharmaceuticals Shareholding Pattern Screener
See J B Chemicals and Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check J B Chemicals and Pharmaceuticals promoter holding and ownership changes for JBCHEPHARM on TickJournal.
| Item | 2026-Jan | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.78% | 47.55% | 47.56% | 47.73% | 47.84% | 53.66% | 53.74% | 53.77% |
| FII Holding | 14.56% | 14.88% | 15.30% | 17.77% | 18.30% | 14.64% | 13.63% | 12.17% |
| DII Holding | 22.71% | 23.36% | 22.83% | 19.63% | 18.72% | 16.41% | 16.81% | 17.62% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% |
| Public Holding | 12.03% | 12.37% | 12.47% | 13.04% | 13.28% | 13.42% | 13.87% | 14.38% |
| Other Holding | 1.92% | 1.85% | 1.84% | 1.83% | 1.86% | 1.87% | 1.94% | 2.05% |
| Shareholder Count | 68,966 | 69,338 | 71,957 | 70,064 | 63,948 | 62,081 | 62,743 | 66,953 |
J B Chemicals and Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check J B Chemicals and Pharmaceuticals dividend history with payout and yield data.
View J B Chemicals and Pharmaceuticals dividend details including ex-dates and amounts for JBCHEPHARM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹15.50 | 0.82% |
| 2024-March | ₹12.25 | 0.75% |
| 2023-March | ₹17.75 | 1.08% |
| 2022-March | ₹16.50 | 1.67% |
| 2021-March | ₹16.50 | 2.10% |
| 2020-March | ₹11.00 | 1.75% |
| 2019-March | ₹5.00 | 1.96% |
| 2018-March | ₹2.00 | 1.10% |
| 2017-March | ₹1.00 | 0.64% |
J B Chemicals and Pharmaceuticals Stock Index Membership
See which indices include J B Chemicals and Pharmaceuticals stock.
Check JBCHEPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
J B Chemicals and Pharmaceuticals Market Events Screener - Corporate Actions
Get J B Chemicals and Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check J B Chemicals and Pharmaceuticals stock events that may affect JBCHEPHARM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2023-05-24 | Split | 1:2 | 0.00% | |
| Dividend | ₹ 8.00 /share | 10.40% | ||
| 2026-02-11 | 2026-02-11 | Dividend | ₹ 12.70 /share | 1.60% |
| 2026-01-16 | 2026-01-16 | Quarterly Result Announcement | NA | 4.16% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 6.12% |
| 2025-08-06 | 2025-08-06 | Annual General Meeting | NA | 4.95% |
| 2025-07-30 | 2025-07-30 | Dividend | ₹ 7.00 /share | 14.10% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | 9.13% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | -4.75% |
| 2025-02-07 | 2025-02-08 | Dividend | ₹ 8.50 /share | -2.35% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -5.04% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -2.31% |
| 2024-08-21 | 2024-08-21 | Annual General Meeting | NA | 8.60% |
| 2024-08-14 | 2024-08-14 | Dividend | ₹ 6.75 /share | 5.95% |
| 2024-02-16 | 2024-02-16 | Dividend | ₹ 5.50 /share | -2.58% |
J B Chemicals and Pharmaceuticals Competitors Screener - Peer Comparison
Screen JBCHEPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
J B Chemicals and Pharmaceuticals Company Announcements - News Screener
Screen JBCHEPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-15 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2026-02-13 | Intimation Of Record Date | View |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors | View |
| 2026-02-13 | Change In Key Managerial Personnel - Letter Of Resignation | View |
| 2026-02-12 | Shifting Of Registered Office | View |
| 2026-02-02 | Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-01-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-24 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | View |
| 2026-01-22 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-21 | Corrigendum To The Outcome Of The First Board Meeting Held On 21 January 2026 | View |
| 2026-01-21 | Disclosure Under Regulation 31A(10)(Ii) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations"). | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2026-01-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On 21 January 2026 | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |